Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-03-01 @ 12:20 AM
Study NCT ID:
NCT06696768
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2024-11-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2024-09416
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None